Impressed

Cronos cannabis surges 11% thanks to the rare "double upgrade"

Snacks / Wednesday, June 05, 2019

Extra green vibes... Last year Canadian cannabis icon Cronos was the first "pure play" pot stock to list on an American exchange. On Wednesday, its shares enjoyed a mellow 11% lifting sensation.

  • Cause: CEO Mike Gorenstein said his company will be "aggressive" with its CBD expansion to the United States, expected this year.
  • Effect: Bank of America's analyst who covers Cronos upgraded the stock by two notches, from "Underperform" to "Buy".

Cronos is hungry for USA... Currently, 99.6% of its sales are in Canada, where recreational Cannabis was legalized last fall. The US is still working on that, but CBD (cannabidiol, which delivers weed's "chill" effect without the "whoa") looks like it's on the faster track to legalization. The TSA is letting some passengers fly with it, and the FDA is holding hearings on its medical benefits.

Altria + Cronos = Big Corporate + Weed Dealer... The analyst highlighted Cronos' 45% owner: American tobacco giant Altria. Altria's access to 230K US stores (Altria already sells cigarettes in them) is key for Cronos to get to US customers before the competition. PS: Cronos' weed brands are compelling — look at this slide deck, page #8:

  • "Spinach" is Cronos' recreational marijuana brand, offering "Farm-To-Bowl" for "consumers that don't take life too seriously."
  • "Cove" is for "premium weed customers... focused on every detail of the process." The stuff is "hand-trimmed."

Get Your News

Subscribe and thrive

Snacks provides fresh takes on the financial news you need to start your day. Chartr provides data visualizations on business, entertainment, and society. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.